XTAI
2823
Dec 17, Last price
30.55TWD
Name
China Life Insurance Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
China Life Insurance Co., Ltd. primarily operates in Taiwan, providing a wide range of insurance products and associated services. The company's diverse portfolio includes individual life and injury coverage, personal health policies, group insurance plans, annuity products, and various investment-linked insurance solutions. Originally known as Overseas Life Insurance Corp., the firm adopted its current name, China Life Insurance Co., Ltd., in 1981. Established in 1963, its corporate headquarters are located in Taipei, Taiwan.
Key people
Jianrong Song
Senior Deputy General Manager · since 2021
Chin Lung Su
Executive Deputy General Manager · since 2021
Anne Su
Senior Deputy General Manager · since 2019
Jina Tsai
Deputy General Manager · since 2020
Jay Ueng
Senior Deputy General Manager, Chief Actuarial Officer · since 2020
Guanqun Wan
Senior Deputy General Manager · since 2022
Caiping Wan
Deputy General Manager · since 2021
Zhao'an Wang
Deputy General Manager · since 2020
Yuefang Xu
Deputy General Manager · since 2020
Yaomin Zhou
Deputy General Manager · since 2020
Stefano Bertamini
Director · since 2021
T.M. Hsu
Chief Executive Deputy General Manager, Corporate Governance Officer, Director · since 2019
Director · since 2022
Su-Kuo Huang
Chairman of the Board · since 2023
Stephanie Hwang
General Manager, Director · since 2021
Independent Director · since 2019
Independent Director · since 2020
Independent Director · since 2020
Cheng-Hsien Tsai
Independent Director · since 2020
Headquarters & legal address
3rd, 4th, 5th, 6th, And 7th Floors
No. 135
Dunhua N. Rd.
Songshan Dist.
Taipei City 105021
TW
No. 135
Dunhua N. Rd.
Songshan Dist.
Taipei City 105021
TW
Trading name
中國人壽保險股份有限公司
Previous name
China Life Insurance Co., Ltd.
Valuation
Title in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||
Revenues | |||||
Cost of revenue | |||||
Unusual Expense (Income) | |||||
NOPBT | |||||
NOPBT Margin | |||||
Operating Taxes | |||||
Tax Rate | |||||
NOPAT | |||||
Net income | |||||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | |||||
BB yield | |||||
| Debt | |||||
Debt current | |||||
Long-term debt | |||||
Deferred revenue | |||||
Other long-term liabilities | |||||
Net debt | |||||
| Cash flow | |||||
Cash from operating activities | |||||
CAPEX | |||||
Cash from investing activities | |||||
Cash from financing activities | |||||
FCF | |||||
| Balance | |||||
Cash | |||||
Long term investments | |||||
Excess cash | |||||
Stockholders' equity | |||||
Invested Capital | |||||
ROIC | |||||
ROCE | |||||
| EV | |||||
Common stock shares outstanding | |||||
Price | |||||
Market cap | |||||
EV | |||||
EBITDA | |||||
EV/EBITDA | |||||
Interest | |||||
Interest/NOPBT |